Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C

• Main Authors: Dorta Guridi Zaily, MD, PhD, MS, PM (Author), Castellanos Fernandez Marlen, MD, PhD, MS, PM (Author), Dueñas-Carrera Santiago, PhD (Author), Martínez Donato Gillian, PhD, MS (Author), Valenzuela Silva Carmen, MS (Author), Cinza Estevez Zurina, MD, MS (Author), Arús Soler Enrique R., MD, PhD, PM (Author), Alvarez-Lajonchere Liz, PhD (Author), González Fabián Lisset, MD, MS (Author), Lazo del Vallín Sacha, MD, MS (Author), Ferrer Bataille Elena, LIC (Author)
• Format: Book
• Published: Elsevier, 2017-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: An estimated 170 million individuals worldwide are infected with the hepatitis C virus (HCV). Although treatment options using a combination of pegylated interferon and ribavirin (P-IFN/RBV) are available, sustained clearance of the virus is only achieved in approximately 40% of individu...